Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 3 | $11,241 |
| Sells | 24 | $259,415 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 20 Nov 2023 21:09 | BOLT | Bolt Biotherapeutics Inc | VIVO CAPITAL VIII, LLC | 10% | 20 Nov 2023 | Sale | 23,443 | 0.92 | 21,568 | I |
| 20 Nov 2023 21:09 | BOLT | Bolt Biotherapeutics Inc | VIVO CAPITAL VIII, LLC | 10% | 20 Nov 2023 | Sale | 3,792 | 0.92 | 3,489 | I |
| 20 Nov 2023 21:09 | BOLT | Bolt Biotherapeutics Inc | VIVO CAPITAL VIII, LLC | 10% | 20 Nov 2023 | Sale | 27,465 | 0.92 | 25,268 | I |
| 20 Nov 2023 21:09 | BOLT | Bolt Biotherapeutics Inc | VIVO CAPITAL VIII, LLC | 10% | 17 Nov 2023 | Sale | 7,009 | 0.93 | 6,518 | I |
| 20 Nov 2023 21:09 | BOLT | Bolt Biotherapeutics Inc | VIVO CAPITAL VIII, LLC | 10% | 17 Nov 2023 | Sale | 1,134 | 0.93 | 1,055 | I |
| 20 Nov 2023 21:09 | BOLT | Bolt Biotherapeutics Inc | VIVO CAPITAL VIII, LLC | 10% | 17 Nov 2023 | Sale | 8,211 | 0.93 | 7,636 | I |
| 20 Nov 2023 21:09 | BOLT | Bolt Biotherapeutics Inc | VIVO CAPITAL VIII, LLC | 10% | 16 Nov 2023 | Sale | 6,429 | 0.96 | 6,172 | I |
| 20 Nov 2023 21:09 | BOLT | Bolt Biotherapeutics Inc | VIVO CAPITAL VIII, LLC | 10% | 16 Nov 2023 | Sale | 1,040 | 0.96 | 998 | I |
| 20 Nov 2023 21:09 | BOLT | Bolt Biotherapeutics Inc | VIVO CAPITAL VIII, LLC | 10% | 16 Nov 2023 | Sale | 7,531 | 0.96 | 7,230 | I |
| 20 Nov 2023 21:31 | BOLT | Bolt Biotherapeutics Inc | ENGLEMAN EDGAR | Director | 20 Nov 2023 | Sale | 3,792 | 0.92 | 3,489 | I |
| 20 Nov 2023 21:31 | BOLT | Bolt Biotherapeutics Inc | ENGLEMAN EDGAR | Director | 17 Nov 2023 | Sale | 1,134 | 0.93 | 1,055 | I |
| 20 Nov 2023 21:31 | BOLT | Bolt Biotherapeutics Inc | ENGLEMAN EDGAR | Director | 16 Nov 2023 | Sale | 1,040 | 0.96 | 998 | I |
| 20 Nov 2023 21:31 | BOLT | Bolt Biotherapeutics Inc | ENGLEMAN EDGAR | Director | 20 Nov 2023 | Sale | 27,465 | 0.92 | 25,268 | I |
| 20 Nov 2023 21:31 | BOLT | Bolt Biotherapeutics Inc | ENGLEMAN EDGAR | Director | 17 Nov 2023 | Sale | 8,211 | 0.93 | 7,636 | I |
| 20 Nov 2023 21:31 | BOLT | Bolt Biotherapeutics Inc | ENGLEMAN EDGAR | Director | 16 Nov 2023 | Sale | 7,531 | 0.96 | 7,230 | I |
| 22 Nov 2023 18:51 | BOLT | Bolt Biotherapeutics Inc | VIVO CAPITAL VIII, LLC | 10% | 21 Nov 2023 | Sale | 1,457 | 0.9 | 1,311 | I |
| 22 Nov 2023 18:51 | BOLT | Bolt Biotherapeutics Inc | VIVO CAPITAL VIII, LLC | 10% | 21 Nov 2023 | Sale | 236 | 0.9 | 212 | I |
| 22 Nov 2023 18:51 | BOLT | Bolt Biotherapeutics Inc | VIVO CAPITAL VIII, LLC | 10% | 21 Nov 2023 | Sale | 1,707 | 0.9 | 1,536 | I |
| 22 Nov 2023 19:45 | BOLT | Bolt Biotherapeutics Inc | ENGLEMAN EDGAR | Director | 21 Nov 2023 | Sale | 236 | 0.9014 | 213 | I |
| 22 Nov 2023 19:45 | BOLT | Bolt Biotherapeutics Inc | ENGLEMAN EDGAR | Director | 21 Nov 2023 | Sale | 1,707 | 0.9014 | 1,539 | I |
| 01 Dec 2023 12:31 | BOLT | Bolt Biotherapeutics Inc | ENGLEMAN EDGAR | Director | 30 Nov 2023 | Sale | 14,934 | 0.8581 | 12,815 | I |
| 01 Dec 2023 12:31 | BOLT | Bolt Biotherapeutics Inc | ENGLEMAN EDGAR | Director | 29 Nov 2023 | Sale | 3,131 | 0.906 | 2,837 | I |
| 01 Dec 2023 12:31 | BOLT | Bolt Biotherapeutics Inc | ENGLEMAN EDGAR | Director | 30 Nov 2023 | Sale | 108,145 | 0.8581 | 92,799 | I |
| 01 Dec 2023 12:31 | BOLT | Bolt Biotherapeutics Inc | ENGLEMAN EDGAR | Director | 29 Nov 2023 | Sale | 22,674 | 0.906 | 20,543 | I |
| 13 Dec 2023 13:40 | BOLT | Bolt Biotherapeutics Inc | QUINN WILLIAM P. | Chief Financial Officer | 12 Dec 2023 | Purchase | 7,500 | 0.95 | 7,125 | D |
| 13 Dec 2023 13:40 | BOLT | Bolt Biotherapeutics Inc | QUINN WILLIAM P. | Chief Financial Officer | 06 Dec 2023 | Purchase | 2,500 | 0.782 | 1,955 | D |
| 13 Dec 2023 13:40 | BOLT | Bolt Biotherapeutics Inc | QUINN WILLIAM P. | Chief Financial Officer | 06 Jun 2023 | Purchase | 1,829 | 1.1815 | 2,161 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)